| 2D Structure | |
| CID | 1549992 |
| Target | APP , CYP2C19 , CYP2C9 , NR1I2 |
| IUPAC Name | (2R)-6-methyl-2-[(1R)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol |
| InChI | InChI=1S/C15H26O/c1-12(2)6-5-11-15(4,16)14-9-7-13(3)8-10-14/h6-7,14,16H,5,8-11H2,1-4H3/t14-,15+/m0/s1 |
| InChI Key | RGZSQWQPBWRIAQ-LSDHHAIUSA-N |
| Canonical SMILES | CC1=CCC(CC1)C(C)(CCC=C(C)C)O |
| Isomeric SMILES | CC1=CC[C@@H](CC1)[C@@](C)(CCC=C(C)C)O |
| Molecular Formula | C15H26O |
| Molecular Weight | 222.37 |
| synonyms | ['alpha-Bisabolol', 'Bisabolol', '515-69-5', '(+)-alpha-Bisabolol', '23178-88-3', '(2R)-6-methyl-2-[(1R)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol', 'D-alpha-Bisabolol', "(+)-(1'R,2R)-alpha-Bisabolol", 'MFCD03846910', 'Dragosantol', 'Camilol', '(AlphaR,1R)-Alpha-Bisabolol', '36HQN158VC', 'CHEMBL1171719', 'DTXSID5045964', 'Hydagen B', '105S6I733Z', '(2R)-6-Methyl-2-(4-methyl-3-cyclohexenyl)-5-heptene-2-ol', '(R)-6-Methyl-2-((R)-4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol', '5-HEPTEN-2-OL, 6-METHYL-2-(4-METHYL-3-CYCLOHEXEN-1-YL)-', 'alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol', 'rel-(R)-6-Methyl-2-((R)-4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol', '3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (R*,R*)-', 'DTXCID3025964', 'dl-.alpha.-Bisabolol', '6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol', 'BISABOLOL, ALPHA', 'CAS-515-69-5', 'BISABOLOL, .ALPHA.', 'RACEMIC ALFA-BISABOLOL', 'alpha-Bisabolol, (+)-', 'UNII-36HQN158VC', 'BISABOLA-1,12-DIEN-8-OL', 'UNII-105S6I733Z', 'alpha-Bisabolol (+)-form [MI]', 'NCGC00095252-01', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-penten-1-yl)-, (alphaR,1R)-rel-', '(+)-a-Bisabolol', 'EINECS 208-205-9', 'EINECS 246-973-7', '+/-alpha-Bisabolol', '(+/-)alpha-Bisabolol', '(+)-.alpha.-Bisabolol', 'BISABOLOL [WHO-DD]', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-penten-1-yl)-, (alphaR,1R)-', 'D-.ALPHA.-BISABOLOL', 'SCHEMBL24988', '(+)-6R,7R-alpha-Bisabolol', '.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol', '.ALPHA.-BISABOLOL [MI]', 'BISABOLOL, (+/-)-', '(R*,R*)-.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol', '(R*,R*)-.alpha.,4-Dimethyl-.alpha.-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol', 'CHEBI:192031', 'ALPHA-BISABOLOL, (+-)-', '3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-penten-1-yl)-, (.alpha.R,1R)-rel-', '(+/-)-.ALPHA.-BISABOLOL', '.ALPHA.-BISABOLOL, (+)-', 'Tox21_111490', 'BDBM50284328', 'MSK158680', 's6136', 'AKOS015969722', 'Tox21_111490_1', '.ALPHA.-BISABOLOL, (+/-)-', '(R*,R*)-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol', 'NCGC00095252-05', '25428-43-7', '( inverted exclamation markA)-|A-Bisabolol', '.ALPHA.-BISABOLOL (+)-FORM [MI]', '1ST158680', 'HY-121222', "(+)-(1'R,2R)-.ALPHA.-BISABOLOL", 'CS-0081254', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-', '(R*,R*)-(1)-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphaR,1R)-rel-', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (R*,R*)-', 'alpha,4-Dimethyl-alpha-(4-methyl-3-penten-1-yl)-(alphaR,1R)-3-Cyclohexene-1-methanol', '3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL- 3-PENTEN-1-YL)-, (.ALPHA.R,1R)-REL-', '3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL- 3-PENTENYL)-, (.THETA.,.THETA.)-(+/-)-', '3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL- 3-PENTENYL)-, (R*,R*)-', '3-CYCLOHEXENE-1-METHANOL, .ALPHA.,4-DIMETHYL-.ALPHA.-(4-METHYL-3-PENTEN-1-YL)-, (.ALPHA.R,1R)-', '3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (theta,theta)-(+/-)-'] |
From Pubchem